Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share Price

Price 12,060.00p on 07-10-2026 at 12:26:52
Change 102.00p 0.85%
Buy 12,064.00p
Sell 12,060.00p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Buy 1.00 at 12,062.00p
Day's Volume: 445,909
Last Close: 11,958.00p
Open: 11,912.00p
ISIN: GB0009895292
Day's Range 11,894.00p - 12,068.00p
52wk Range: 11,404.00p - 15,730.00p
Market Capitalisation: £187.04b
VWAP: 11,793.19664p
Shares in Issue: 1.55b

Sector: Medicine and Biotech

Listed In: FTSE All-Share, FTSE All-Share ex Investment Trusts, FTSE Lower Yield, FTSE 350 ex Investment Trusts, FTSE 350 , FTSE 100,

Astrazeneca (AZN) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 1 12,062.00p Ordinary
 13:26:47 - 07-Oct-26
Unknown* 127 12,060.00p SI Trade
 13:26:38 - 07-Oct-26
Unknown* 187 12,060.00p SI Trade
 13:26:38 - 07-Oct-26
Sell* 120 12,060.00p Automatic Execution
 13:26:38 - 07-Oct-26
Sell* 2 12,060.00p Automatic Execution
 13:26:38 - 07-Oct-26
Sell* 130 12,060.00p Automatic Execution
 13:26:38 - 07-Oct-26
Sell* 122 12,064.00p Automatic Execution
 13:26:36 - 07-Oct-26
Sell* 106 12,066.00p Automatic Execution
 13:26:34 - 07-Oct-26
Sell* 64 12,066.00p Automatic Execution
 13:26:34 - 07-Oct-26
Sell* 31 12,066.00p Automatic Execution
 13:26:34 - 07-Oct-26
See more Astrazeneca trades

Astrazeneca (AZN) Share Price History

Time period:
to
Date Open High Low Close Volume
6th Oct 2026 (Tue) 11,904.00 12,108.00 11,782.00 11,958.00 2,188,384
5th Oct 2026 (Mon) 11,900.00 11,970.00 11,716.00 11,764.00 1,618,185
2nd Oct 2026 (Fri) 11,800.00 12,094.00 11,790.00 11,870.00 1,658,617
1st Oct 2026 (Thu) 12,014.00 12,200.00 12,011.00 12,032.00 3,716,388
30th Sep 2026 (Wed) 12,436.00 12,514.00 12,250.00 12,280.00 3,855,381
29th Sep 2026 (Tue) 12,526.00 12,786.00 12,386.00 12,428.00 2,734,917
28th Sep 2026 (Mon) 12,614.00 12,626.00 12,448.00 12,492.00 1,550,487
25th Sep 2026 (Fri) 12,400.00 12,614.00 12,398.00 12,552.00 1,735,427
24th Sep 2026 (Thu) 12,418.00 12,506.00 12,316.00 12,400.00 2,111,817
23rd Sep 2026 (Wed) 12,564.00 12,660.00 12,430.00 12,430.00 1,690,123
22nd Sep 2026 (Tue) 12,606.00 12,688.00 12,478.00 12,672.00 4,821,323
21st Sep 2026 (Mon) 12,450.00 12,630.00 12,364.00 12,560.00 3,916,309
18th Sep 2026 (Fri) 12,460.00 12,596.00 12,398.00 12,500.00 6,542,628
17th Sep 2026 (Thu) 12,202.00 12,428.00 12,148.00 12,428.00 2,814,932
16th Sep 2026 (Wed) 12,098.00 12,296.00 12,074.00 12,136.00 5,326,814
15th Sep 2026 (Tue) 12,236.00 12,236.00 11,922.00 12,116.00 3,056,568
14th Sep 2026 (Mon) 11,698.00 12,216.00 11,692.00 12,154.00 6,469,579
11th Sep 2026 (Fri) 11,810.00 11,960.00 11,708.00 11,708.00 1,474,394
10th Sep 2026 (Thu) 11,634.00 11,802.00 11,552.00 11,758.00 2,069,750
9th Sep 2026 (Wed) 11,850.00 11,996.00 11,598.00 11,650.00 3,565,541
8th Sep 2026 (Tue) 11,958.00 12,122.00 11,852.00 11,876.00 2,301,862
7th Sep 2026 (Mon) 11,986.00 12,210.00 11,952.00 12,042.00 1,975,838
See more Astrazeneca price history

Astrazeneca (AZN) Regulatory News

Date Source Headline
5th Oct 2026 12:00 pm RNS AstraZeneca completes equity investment in Summit
2nd Oct 2026 7:30 am RNS AZ & DS collaboration with Summit for Datroway
1st Oct 2026 3:05 pm RNS Admission of Further Securities to Trading
1st Oct 2026 3:00 pm RNS Total Voting Rights
29th Sep 2026 7:00 am RNS AstraZeneca announces equity investment in Summit
23rd Sep 2026 7:00 am RNS Trixeo approved in EU for asthma
21st Sep 2026 7:05 am RNS Klygefa recommended for EU approval by CHMP
21st Sep 2026 7:00 am RNS Enhertu recommended for approval in EU in early BC
18th Sep 2026 11:00 am RNS Director/PDMR Shareholding
15th Sep 2026 3:05 pm RNS Director/PDMR Shareholding
See more Astrazeneca regulatory news

Astrazeneca (AZN) Share News

LONDON BROKER RATINGS: Deutsche Bank ups Glencore, BHP price targets

7th Oct 2026 09:05

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More

AztraZeneca opens new global strategic R&D centre in Massachusetts

5th Oct 2026 19:28

(Alliance News) - AstraZeneca PLC on Monday announced the opening of its newest global strategic research and development centre, in Massachusetts. Read More

IN BRIEF: AstraZeneca completes USD2 billion Summit investment

5th Oct 2026 12:53

AstraZeneca PLC - Cambridge, England-based pharmaceutical company - Says it has successfully completed its USD2 billion equity investment in Summit Therapeutics. The funding will accelerate the development of first-in-class bispecific antibody ivonescimab, which targets PD-1 and VEGF across multiple tumour types in combination with antibody-drug conjugates. Notes that it has also entered a clinical collaboration agreement with Summit to evaluate sonesitatug vedotin in combination with ivonescimab. They also intend to enter an additional deal, which would initiate a global development programme combining other AstraZeneca cancer medicines. Read More

Daiichi, AstraZeneca enter clinical trial cooperation with Summit

2nd Oct 2026 10:14

(Alliance News) - Daiichi Sankyo Co Ltd and AstraZeneca PLC on Friday said they entered into a clinical trial collaboration with the biopharmaceutical oncology company Summit Therapeutics Inc to evaluate the use of Datroway in combination with ivonescimab in treating multiple tumour types. Read More

WINNERS & LOSERS: Vesuvius soars on bid; Zigup lifts outlook

29th Sep 2026 10:21

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Tuesday. Read More

See more Astrazeneca news
FTSE 100 Latest
Value10,479.64
Change-62.05

Login to your account

Forgot Password?

Not Registered